Wolverine Trading, LLC Arcturus Therapeutics Holdings Inc. Transaction History

Wolverine Trading, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$25.79 - $42.11 $155,616 - $254,091	-6,034 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$38.75 - $86.92 $193,750 - $434,600	-5,000 Reduced 45.31%	6,034 $234,000
Q4 2020 Feb 12, 2021	SELL	$34.61 - $123.66 $32,083 - $114,632	-927 Reduced 7.75%	11,034 $515,000
Q3 2020 Nov 13, 2020	SELL	$37.49 - $63.19 $304,231 - $512,786	-8,115 Reduced 40.42%	11,961 $511,000
Q2 2020 Aug 13, 2020	BUY	$12.66 - $58.27 $254,162 - $1.17 Million	20,076 New	20,076 $943,000

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $439M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.